Guerbet S.A.

Guerbet is a French pharmaceutical group that develops, markets, and provides maintenance services for medical equipment and devices destined for diagnostic and interventional imaging. Co.'s portfolio comprises media solutions covering MRI, X-rays and products devoted to International Radiology and Theranostics and medical devices. Co. organizes its operation by product family covering Magnetic Resonance Imaging (MRI), X-rays (XR) and Interventional Radiology and Theranostics (IRT). The MRI family includes Dotarem® and Artirem®; Co.'s X-ray product family includes Xenetix®, Optiray®/Optiject®, Oxilan®, and Telebrix®; and the IRT product family has Lipiodol®, Bleu Patente V and Hexabrix®.
  • TickerGBT
  • ISINFR0000032526
  • ExchangeEuronext Paris
  • SectorPharmaceuticals & Biotechnology
  • CountryFrance

Analysts

1 director sold

A director at Guerbet sold 4,250 shares at 54.095EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board members...

Christophe-Raphaël Ganet

Guerbet : The “Untouchables”

In a persistently restrictive environment for midcaps, we are updating our stock selection. We select those for which cash flow seems to us to be fairly secure, free of geopolitical or interest rate sensitivity, while hoping for momentum effects (triggers), and with multiples as reasonable as possible. Thus, we maintain Albioma, Devoteam and Wordline in our list to which we have also added Guerbet, Ipsen, SMCP and Spie. - >Persistently unfavourable context? - The macro...

Christophe-Raphaël Ganet

Guerbet : Les « Affranchies »

Dans un environnement qui nous parait devoir être encore contraignant pour les Midcaps, nous mettons à jour notre sélection de valeurs. Nous retenons celles dont le cash-flow nous paraît assez sécurisé, affranchies de sensibilité géopolitique ou taux, tout en espérant des effets de momentum (triggers), et avec des multiples aussi raisonnables que possible. Ainsi restent dans la liste Albioma, Devoteam et Wordline alors qu’entrent Guerbet, Ipsen, SMCP et Spie. - >Contexte t...

Pierre Vaurice

Conference Feedback Midcap Partners. GUERBET: 2019 starts positively

Conference Feedback Midcap Partners. GUERBET: 2019 starts positively

Pierre Vaurice

Feedback Conférence Midcap Partners. GUERBET: 2019 démarre positivement

Feedback Conférence Midcap Partners. GUERBET: 2019 démarre positivement

Christophe-Raphaël Ganet

Guerbet : The “Untouchables”

In a persistently restrictive environment for midcaps, we are updating our stock selection. We select those for which cash flow seems to us to be fairly secure, free of geopolitical or interest rate sensitivity, while hoping for momentum effects (triggers), and with multiples as reasonable as possible. Thus, we maintain Albioma, Devoteam and Wordline in our list to which we have also added Guerbet, Ipsen, SMCP and Spie. - >Persistently unfavourable context? - The macro...

Christophe-Raphaël Ganet

Guerbet : Les « Affranchies »

Dans un environnement qui nous parait devoir être encore contraignant pour les Midcaps, nous mettons à jour notre sélection de valeurs. Nous retenons celles dont le cash-flow nous paraît assez sécurisé, affranchies de sensibilité géopolitique ou taux, tout en espérant des effets de momentum (triggers), et avec des multiples aussi raisonnables que possible. Ainsi restent dans la liste Albioma, Devoteam et Wordline alors qu’entrent Guerbet, Ipsen, SMCP et Spie. - >Contexte t...

Pierre Vaurice

Conference Feedback Midcap Partners. GUERBET: 2019 starts positively

Conference Feedback Midcap Partners. GUERBET: 2019 starts positively

Pierre Vaurice

Feedback Conférence Midcap Partners. GUERBET: 2019 démarre positivement

Feedback Conférence Midcap Partners. GUERBET: 2019 démarre positivement

Aurelien Sivignon ...
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Fehmi Ben Naamane
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Johanna Jourdain
  • Louis Boujard
  • Michael Foundoukidis
  • Nicolas Thorez
  • Philippe Ourpatian
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 04/23/2019

...

1 director sold

A director at Guerbet sold 4,250 shares at 54.095EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board members...

Amine Daly ...
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Jeremy Garnier
  • Nicolas Thorez
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 03/28/2019

...

Amine Daly ...
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Jeremy Garnier
  • Nicolas Thorez
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 28/03/2019

...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Hana Maalej
  • Jean-François Granjon
  • Jeremy Garnier
  • Khaled Ben Amor
  • Nicolas Thorez

ODDO BHF Small & MIDCAP MORNING NEWS - 03/27/2019

...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Christophe-Raphaël Ganet
  • Fatma Agnès Hamdani
  • Hana Maalej
  • Jean-François Granjon
  • Jeremy Garnier
  • Khaled Ben Amor
  • Nicolas Thorez

ODDO BHF Small & MIDCAP MORNING NEWS - 27/03/2019

...

Aurelien Sivignon ...
  • Charles Lepetitpas
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Michael Foundoukidis
  • Nicolas David
  • Salma Bouraoui
  • Sven Edelfelt
  • Team Pharma
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 10/26/2018 Date Performance since listing Date Performance since listing

...

Due to a more favourable environment, GUERBET slightly increases to Neutral

GUERBET (FR), a company active in the Pharmaceuticals industry, slightly increases its general evaluation. The independent financial analyst theScreener just confirmed the stock market behaviour of the title as moderately risky. At the fundamental level, theScreener confirms the rating of 1 out of 4 stars; given the more favourable environment, the title's overall rating is upgraded to Neutral even if it remains under pressure. As of the analysis date May 17, 2019, the closing price was EUR 49.55 and its target price was estimated at EUR 43.70.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Charles Pinel

Guerbet SA - Assemblée Générale des actionnaires du 24 mai 2019

Le conseil d'administration ne comprendra plus de dirigeant car le mandat d'administrateur du Directeur Général qui arrive à échéance n'est pas renouvelé. Il comprendra donc 10 membres contre 11 précédemment mais il est toujours composé d'une majorité de membres non libres de conflits d'intérêts potentiels, ce qui ne permet pas d'approuver le renouvellement d'un membre de la famille Guerbet, d'autant plus que cette famille est en sur-représentation avec 60% des sièges du conseil pour 53% du capital (résolution 13). Comme chaque année, les politiques de rémunération des dirigeants mandataires ...

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

SRI Company Analysis

Geol analyses are ESG (Environment, Social, Governance) analyses covering European large caps and small and mid caps, listed or non-listed. Those analyses, based on the ESG risks identified, show the qualitative and quantitative performance of issuers, in a ten-page synthesis.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch